Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method

Veronica Popescu1, Menno M Schoonheim2, Adriaan Versteeg1

  • 1Department of Radiology and Nuclear Medicine, Neuroscience Campus Amsterdam (NCA), VU University Medical Center, Amsterdam, The Netherlands.

Plos One
|January 9, 2016
PubMed
Abstract

Insights

Grey matter (GM) atrophy measurements in multiple sclerosis (MS) brains vary across software. While software can distinguish MS patients from controls, correlations with cognition require cautious interpretation due to differing results.

Area of Science:

  • Neuroimaging
  • Neurology
  • Medical image analysis

Background:

  • Multiple Sclerosis (MS) brain grey matter (GM) atrophy location is inconsistently reported.
  • Discrepancies exist in studies examining GM atrophy in MS.

Purpose of the Study:

  • To assess the consistency of grey matter (GM) atrophy measurements using FSL, FreeSurfer, and SPM in multiple sclerosis (MS) brains.
  • To compare volumetric data, patient/control discrimination, and cognitive correlations across different neuroimaging analysis software.

Main Methods:

  • Included 127 MS patients and 50 controls for cortical and deep grey matter (DGM) volumetrics.
  • Assessed volume consistency using Intraclass Correlation Coefficient (ICC).
  • Evaluated patient/control discrimination and cognitive associations using statistical tests and machine learning classifiers.

Main Results:

  • Highest volumetric ICC between SPM and FreeSurfer for cortical regions; lowest for DGM.
  • Caudate nucleus and temporal lobes showed high consistency; amygdala showed low consistency.
  • Deep grey matter (DGM) demonstrated better patient/control discrimination and stronger cognitive correlations than cortical volumes.

Conclusions:

  • Grey matter (GM) volumes derived from FreeSurfer, FSL, and SPM differ, particularly in cortical regions.
  • While software can differentiate MS patients from controls, correlations between regional GM volumes and clinical/cognitive variables in MS warrant careful consideration.

Related Concept Videos